These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18214640)

  • 41. Serine/threonine phosphatases: mechanism through structure.
    Shi Y
    Cell; 2009 Oct; 139(3):468-84. PubMed ID: 19879837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
    Kim KY; Baek A; Hwang JE; Choi YA; Jeong J; Lee MS; Cho DH; Lim JS; Kim KI; Yang Y
    Cancer Res; 2009 May; 69(9):4018-26. PubMed ID: 19366811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liprin alpha1 interacts with PP2A B56gamma.
    Arroyo JD; Lee GM; Hahn WC
    Cell Cycle; 2008 Feb; 7(4):525-32. PubMed ID: 18235218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of protein phosphatase 2A with polyoma virus medium tumor antigen.
    Walter G; Ruediger R; Slaughter C; Mumby M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2521-5. PubMed ID: 2157202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein phosphatase 2A isoforms utilizing Aβ scaffolds regulate differentiation through control of Akt protein.
    Hwang JH; Jiang T; Kulkarni S; Faure N; Schaffhausen BS
    J Biol Chem; 2013 Nov; 288(44):32064-73. PubMed ID: 24052256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
    Kim JW; Berrios C; Kim M; Schade AE; Adelmant G; Yeerna H; Damato E; Iniguez AB; Florens L; Washburn MP; Stegmaier K; Gray NS; Tamayo P; Gjoerup O; Marto JA; DeCaprio J; Hahn WC
    Elife; 2020 Jan; 9():. PubMed ID: 31913126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.
    Kauko O; Westermarck J
    Int J Biochem Cell Biol; 2018 Mar; 96():157-164. PubMed ID: 29355757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.
    Zhao J; Wu HW; Chen YJ; Tian HP; Li LX; Han X; Guo J
    J Neurosci Res; 2008 Sep; 86(12):2733-45. PubMed ID: 18478546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
    Chen L; Liu L; Yin J; Luo Y; Huang S
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentoxifylline prevents loss of PP2A phosphatase activity and recruitment of histone acetyltransferases to proinflammatory genes in acute pancreatitis.
    Sandoval J; Escobar J; Pereda J; Sacilotto N; Rodriguez JL; Sabater L; Aparisi L; Franco L; López-Rodas G; Sastre J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):609-17. PubMed ID: 19671881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physical association of GPR54 C-terminal with protein phosphatase 2A.
    Evans BJ; Wang Z; Mobley L; Khosravi D; Fujii N; Navenot JM; Peiper SC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1067-71. PubMed ID: 18977201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen.
    Kotadia S; Kao LR; Comerford SA; Jones RT; Hammer RE; Megraw TL
    Oncogene; 2008 Oct; 27(49):6334-46. PubMed ID: 18663356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.
    Grech G; Baldacchino S; Saliba C; Grixti MP; Gauci R; Petroni V; Fenech AG; Scerri C
    Tumour Biol; 2016 Sep; 37(9):11691-11700. PubMed ID: 27444275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic targeting of PP2A.
    O'Connor CM; Perl A; Leonard D; Sangodkar J; Narla G
    Int J Biochem Cell Biol; 2018 Mar; 96():182-193. PubMed ID: 29107183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
    Carratù MR; Signorile A; De Rasmo D; Reale A; Vacca A
    Curr Med Chem; 2016; 23(38):4286-4296. PubMed ID: 27758717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity.
    Chen W; Arroyo JD; Timmons JC; Possemato R; Hahn WC
    Cancer Res; 2005 Sep; 65(18):8183-92. PubMed ID: 16166293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
    Perrotti D; Neviani P
    Cancer Metastasis Rev; 2008 Jun; 27(2):159-68. PubMed ID: 18213449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back.
    Westermarck J
    FEBS J; 2018 Nov; 285(22):4139-4145. PubMed ID: 30055114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein Phosphatase 2A in the Regulation of Wnt Signaling, Stem Cells, and Cancer.
    Thompson JJ; Williams CS
    Genes (Basel); 2018 Feb; 9(3):. PubMed ID: 29495399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous transformation of an immortalized hepatocyte cell line: potential role of a nuclear protease.
    Drubin DA; Clawson GA
    Cancer Lett; 2004 Sep; 213(1):39-48. PubMed ID: 15312682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.